Pharma
Deals

Torrent Pharma is gearing up to take over Cipla. Here’s why it’s a tightrope walk.

Torrent Pharma is gearing up to take over Cipla. Here’s why it’s a tightrope walk.
Getty Images

Synopsis

If Torrent Pharma were to acquire Cipla, which is 2.5 times its size in sales, it would be a bold move. While the acquisition would catapult Torrent to the top of the heap in the domestic market and make it the second-largest Indian pharma company in terms of revenue, financing the deal and integration can pose a litany of challenges.

By &
14 mins read, Last Updated:
A historic takeover in the Indian pharmaceutical sector is on the cards. A company that was seen as one of India’s strongest and identified as the country’s pride is at the centre of frenetic moves. Built arduously over nine decades, Cipla founders, the Hamied family, are seeking out buyers. The frontrunner in the race is Ahmedabad-based Torrent Pharmaceuticals, part of the power-to-pharmaceuticals group run by brothers Sudhir Mehta and Samir

To Read the Full Story, Become an ET Prime Member

Access the exclusive Economic Times stories, Editorial and Expert opinion

Subscribe Now

Monsoon Offer

Get flat 20% off

on ETPrime membership

Membership Benefits

Access the exclusive Economic Times

Stories, Editorial & Expert opinion

Complete Access with ET Prime

Experience your Economic Times newspaper, The way you've always liked!

Get to know where the market gurus invest & grow your portfolio.

Stock Report Plus

In-depth stock analysis for 4000+ companies

Stock Analyzer

Instant stock analysis based on Solvency, Profitability, Growth, Valuation, Momentum, Risk & More.

Now Available with ET Prime

Manage your money efficiently with this weekly guide.

Clean experience

with minimal ads

Easy & distraction-free reading with 90% less ads

Sharp Insight-rich,

In-depth stories across 20+ sectors

1500+ Exclusive stories & analysis across sectors to help you stay informed

Get One Year Times Prime Subscription worth ₹1199 for free

Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-

Enjoy unlimited access to breaking news and thought provoking stories from all around the world.

Get One Year Docubay Subscription worth ₹999 for free

Stream award-winning international documentaries from more than 100 countries.

Offers By Our Partners

Exclusively for ET Prime Members

Members Love Us

The stalwarts of the industry trust ET Prime for insightful analysis & unbiased thought pieces

Gift a story

Your membership includes Story Gifting Credits. Now gift exclusive stories to your friends & peers.

Comment & Engage

with ET Prime community

Communicate & build a connection with great minds of the industry

A trusted team of

Journalists & Analysts

Unbiased perspective & detailed reporting by our team of journalists who have in-depth knowledge and years of experience